Hepatitis C testing, treatment and prevention in low- and middle-income country prisons

Joseph D Tucker; Ahsan Ahmad; Andargachew Mulu; Monde Muyoyeta; Muhammad Radzi Abu Hassan; Adeeba Kamarulzaman

doi:10.1038/s41575-022-00645-3

Hepatitis C testing, treatment and prevention in low- and middle-income country prisons

Nat Rev Gastroenterol Hepatol. 2022 Aug;19(8):484-485. doi: 10.1038/s41575-022-00645-3.

Authors

Joseph D Tucker^{1

2}, Ahsan Ahmad^{3

4}, Andargachew Mulu⁵, Monde Muyoyeta⁶, Muhammad Radzi Abu Hassan^{7

8}, Adeeba Kamarulzaman^{3

4}

Affiliations

¹ Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA. jdtucker@med.unc.edu.
² Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK. jdtucker@med.unc.edu.
³ Section of Infectious Diseases, Department of Internal Medicine, Yale University, New Haven, CT, USA.
⁴ Infectious Diseases Unit, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
⁵ Viral Diseases Research Team, Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
⁶ Tuberculosis Programs Division, Center for Infectious Diseases Research in Zambia, Lusaka, Zambia.
⁷ Internal Medicine Service, Malaysian Ministry of Health, Kuala Lumpur, Malaysia.
⁸ Clinical Research Department, Hospital Sultanah Bahiyah, Alor Setar, Kedah, Malaysia.

Abstract

Hepatitis C virus (HCV) infection is common among people who are incarcerated in low- and middle-income countries. Prison policy changes towards HCV testing and treatment are pivotal for social justice and can be a crucial step for achieving HCV global elimination targets.

MeSH terms

Hepatitis C* / diagnosis
Hepatitis C* / drug therapy
Hepatitis C* / epidemiology
Humans
Prisons*